Antibody Engineering Company F-Star Buys Back Royalty Obligations
TVM Capital Joins Investor Syndicate
01-Apr-2008 -
f-star announced that it has acquired future royalty obligations to New Century Pharmaceuticals (NCP) via a one-off payment.
Modular Antibody Technology was originally developed by Prof. Florian Rueker, one of f-star's founders, in collaboration with NCP, a U.S. biopharmaceutical company. After ...
Life Sciences
venture capital